Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Recombinant long-acting HGH (human growth hormone) fusion protein and preparation and application thereof

A fusion protein and growth hormone technology, applied in the direction of growth hormone, animal/human protein, hormone peptide, etc., can solve the problems of low long-term effect, loss of activity, and lower specific activity of growth hormone

Inactive Publication Date: 2018-11-13
SYNDEGEN SHANGHAI BIOTECH
View PDF3 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the performance of these modified or engineered GHs is still unsatisfactory, and there are some obvious disadvantages: such as low long-acting (difficult to achieve long-acting once a week or higher), or low activity
For example, take PEG (polyethylene glycol) growth hormone as an example. Although growth hormone can significantly increase the half-life of the drug to make it long-acting after being modified with polyethylene glycol, growth hormone often causes activity during the PEGylation production process. Loss of growth hormone specific activity
In addition, PEGylated growth hormone also reduces the affinity of the hormone for the receptor

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Recombinant long-acting HGH (human growth hormone) fusion protein and preparation and application thereof
  • Recombinant long-acting HGH (human growth hormone) fusion protein and preparation and application thereof
  • Recombinant long-acting HGH (human growth hormone) fusion protein and preparation and application thereof

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0139] Preparation of fusion protein

[0140] As used herein, "isolated" means that the material is separated from its original environment (if the material is native, the original environment is the natural environment). For example, polynucleotides and polypeptides in the natural state in living cells are not isolated and purified, but the same polynucleotides or polypeptides are isolated and purified if they are separated from other substances that exist together in the natural state.

[0141] As used herein, "isolated recombinant fusion protein" means that the recombinant fusion protein is substantially free of other proteins, lipids, carbohydrates or other substances with which it is naturally associated. Those skilled in the art can purify recombinant fusion proteins using standard protein purification techniques. Essentially pure proteins yield a single major band on non-reducing polyacrylamide gels.

[0142] A polynucleotide of the invention may be in the form of DNA...

Embodiment 1

[0187] Embodiment 1 investigates the proportion of monomeric molecules in cell culture of GHFc-1-3 and GHFc-3-1 two kinds of molecules

[0188] In order to make it easier for GHFc molecules to form a monomeric form in the cell, that is, the GH-(Fc)*2 form, the present invention mutates some amino acids of the IgG4-Fc part, thereby making it easier to form the GH-(Fc)*2 form. And the connection between Fc and GH of different mutations is also the object of investigation in the present invention, and two kinds of molecules have been designed (see figure 2 ):

[0189] One of the molecules is a GH sequence using a linker peptide and IgG4-Fc containing (1), (2), (3), (4) in the first type of mutation and (1) in the above-mentioned second type of mutation (i.e. M2-IgG4-Fc, referred to as mut3) is linked to IgG4-Fc containing (1), (2), (3), (4) in the above-mentioned first type of mutation and (2) in the above-mentioned second type of mutation (ie M3-IgG4-Fc, referred to as mut 1)...

Embodiment 2

[0203] Example 2 In vitro biological activity analysis of hGH-L-Fc

[0204] The growth hormone biological activity assay is a cell-based receptor titer increase assay, namely the BAF method.

[0205] The BAF cell line responds to GH in a dose-dependent growth pattern, so it can be used to evaluate the role of GH in proliferation assays. The BAF cell line was cultured in DMEM high-glucose medium supplemented with 10% horse serum for 16 hours. , adjust the cell density to 3*10^5 / ml, take 100 microliters and drop them into 96-well plates after mixing. Dilute the standard GH solution to a final concentration of 0.01-1000.00ug / L, add 10ul of the standard GH solution dropwise to a 96-well plate, and incubate for 22 hours. Add 22ul of reaction solution to each well, continue to incubate for 3 hours, and measure the absorbance at 490nm. Draw the standard curve of the relationship between absorbance value and GH biological activity equivalent. 10ul of different growth hormone compou...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
molecular weightaaaaaaaaaa
Login to View More

Abstract

The invention provides a recombinant long-acting HGH (human growth hormone) fusion protein and preparation and application thereof, particularly provides a fusion protein having the structure as shownas the formula I, wherein X refers to GH element, Y1 and Y2 refer to Fc elements respectively, L refers to None or linker peptide, ' ' refers to a covalent bond (such as a peptide bond), '... 'represents n interchain disulfide bonds between Y1 andY2, and n is 1, 2, 3, 4, 5, or 6.

Description

technical field [0001] The present invention relates to the field of medicine, more specifically, relates to recombinant long-acting human growth hormone fusion protein and its preparation and application. Background technique [0002] Growth hormone (HGH) is a peptide hormone that is synthesized, stored and secreted by somatotroph cells in the pituitary gland. The growth hormone molecule is composed of 191 amino acid residues with a relative molecular mass of 22124 Daltons. Growth hormone binds to its growth hormone receptor (hGHR) on the surface of target cells, activating a biological response. [0003] Growth hormone can promote animal and human development and cell proliferation. One of the main physiological effects of growth hormone is to promote the synthesis of various tissues in the human body, especially protein, and can stimulate the growth of articular cartilage and epiphyseal cartilage, thus increasing height. Once the human body lacks growth hormone, it wil...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07K19/00C12N15/62C12P21/02A61K38/27A61P5/06
CPCC07K14/61A61K38/00C07K2319/30
Inventor 许必雄郭颀然
Owner SYNDEGEN SHANGHAI BIOTECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com